Tara SharifAdvisory Board
Tara Sharif is an investment banker and advisor, providing financial and strategic advisory services to healthcare and life sciences corporations. Tara is registered with Crito Capital, LLC as a Managing Director, and with FINRA, holding series 7 and 63 licenses.
Tara completed a PhD in developmental and cellular biology at Southern Illinois University where she studied cellular de-differentiation and commitment plasticity as related to cancer, and taught histology to medical students. Subsequently, she completed a post-doctoral fellowship at University of Missouri-Columbia, studying early embryonic gene expression and immunity.
After 11 years of academic research and mentoring at Cornell Medical College, and completion of an MBA in Finance, from Fordham Graduate School of Business Administration in 1999, she transitioned to the private sector.
Since then she has held investment banking and advisory positions at Arthur Andersen, LLP; Maxim Group, LLC; Newbridge Securities, WestPark Capital and now at Crito Capital. At this capacity, she has worked in the areas of corporate strategy, private and public financing, M&A, and joint venture in a number of domestic and cross-border transactions.
Aside from her main role, Dr. Sharif serves on external advisory boards of LIBH and Springboard and acts as the interim CEO of Tarachon, LLC.
Tara has completed three (3) New York City Marathon races.